Hu Said: Cardiology Board Review Series

In what settings should you use the H₂FPEF, HFA-PEFF, and HFpEF-ABA scores in the diagnosis of HFpEF? What are HFpEF mimics? What is the difference between OMT and GDMT? Why is finerenone now preferred over spironolactone as the mineralocorticoid antagonist of choice in HFpEF? In which HFpEF patients should semaglutide or tirzepatide be prescribed? Why should ACE inhibitors be avoided in HFpEF, and which RAAS agents are actually supported by evidence? In which specific subgroups of HFpEF patients should sacubitril/valsartan be considered? Should HFpEF patients be given beta blockade? Which diabetes medications should be avoided in HFpEF patients, and which should replace them? How does the cardiovascular-kidney-metabolic framework help prioritize therapies with overlapping benefits across heart failure, diabetes, CKD, and obesity? Watch for answers to these key questions and more in this deep dive of the 2026 ACC Expert Consensus Decision Pathway on the Management of Heart Failure with Preserved Ejection Fraction.

Watch on YouTube: https://youtu.be/HazAsFCjiAI

Difficulty Level: Medium

You are listening to Hu Said: Guideline Lifeline
Please subscribe, rate, and support the channel! Ads help keep materials free for everyone.
More MedEd resources available at ⁠⁠⁠⁠⁠www.rueyhu.com⁠⁠⁠⁠⁠
Updates at Twitter/X: ⁠⁠⁠⁠⁠@Ruey_Hu⁠

Why did the 2026 universal definition abandon specific numerical cutoffs for HFrEF and HFpEF? What are the three positive trajectories that can emerge from symptomatic HF? How do impHF (heart failure with improvement), remHF (heart failure with remission), and recHF (heart failure with recovery) differ from one another? What is the distinction between worsening HF and decompensated HF? What are the categories in the new Universal Classification of HF by Cause? How does the cause of HF differ between geographic regions? Watch for answers to these key questions and more in this deep dive of the 2026 AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure.

Watch on YouTube: https://youtu.be/MR20wFklefg

Difficulty Level: Easy

You are listening to Hu Said: Guideline Lifeline
Please subscribe, rate, and support the channel! Ads help keep materials free for everyone.
More MedEd resources available at ⁠⁠⁠⁠⁠www.rueyhu.com⁠⁠⁠⁠⁠
Updates at Twitter/X: ⁠⁠⁠⁠⁠@Ruey_Hu⁠

When should apoB be measured? In whom should lipoprotein(a) be measured? Should LDL-C be calculated by the Friedewald, Martin-Hopkins, or Sampson-NIH equations? How do the PREVENT-ASCVD equations differ from the Pooled Cohort Equations? How long is a coronary artery calcium (CAC) score of 0 "good for"? How should CAC scoring be used to guide statin initiation and intensity? What are the new LDL-C, non-HDL-C, and apoB targets for secondary prevention? What counts as "very high-risk" ASCVD, and how does treatment differ? In which patients should bempedoic acid, inclisiran, or olezarsen be added? Watch for answers to these key questions and more in this "deep dive" of the 2026 ACC/AHA Guideline on the Management of Dyslipidemia.

Watch on YouTube: https://youtu.be/yHXL_dH8zCo

Difficulty Level: Easy

You are listening to Hu Said: Guideline Lifeline
Please subscribe, rate, and support the channel! Ads help keep materials free for everyone.
More MedEd resources available at ⁠⁠⁠⁠www.rueyhu.com⁠⁠⁠⁠
Updates at Twitter/X: ⁠⁠⁠⁠@Ruey_Hu⁠

What is the new 2026 classification for acute pulmonary embolism? What is the respiratory modifier? What category encompasses normotensive shock? What is the difference between the PESI score, sPESI score, Hestia score, and CPES score? Should LMWH or unfractionated heparin be used for initial parenteral anticoagulation for PE? What anticoagulation agent for PE is recommended in patients with antiphospholipid syndrome, chronic kidney disease, brain tumors, or pregnancy? In which patients is systemic lysis, catheter-directed thrombolysis, mechanical thrombectomy, or surgery appropriate? How should clot-in-transit be managed? Is there a role for pulmonary vasodilators? How should vasopressors be dosed in acute PE? How is CTEPD different from CTEPH? How long should anticoagulation be continued after PE? Watch for answers to these key questions in this "deep dive" of the 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults — the first-ever dedicated AHA/ACC guideline on acute PE.This episode also available on YouTube: https://youtu.be/rE-I4Jwq1UA

Difficulty Level: Easy

You are listening to Hu Said: Guideline Lifeline
Please subscribe, rate, and support the channel! Ads help keep materials free for everyone.
More MedEd resources available at ⁠⁠⁠⁠⁠www.rueyhu.com⁠⁠⁠⁠⁠
Updates at Twitter/X: ⁠⁠⁠⁠⁠@Ruey_Hu⁠

What right ventricular end-systolic volume should guide timing of pulmonary valve replacement in tetralogy of Fallot? At what pulmonary vascular resistance can closure be pursued for an atrial septal defect in patients with pulmonary hypertension? How often should Fontan patients receive liver imaging and alpha-fetoprotein screening? Should patients with Eisenmenger syndrome be routinely anticoagulated? What is the maternal mortality risk for pregnancy in Eisenmenger syndrome? Should most pregnant patients with adult congenital heart disease undergo cesarean delivery? Should cyanotic ACHD patients undergo prophylactic phlebotomy? Can ACHD patients participate in competitive sports? Watch for answers to these key questions in this "deep dive" of the 2025 ACC/AHA Guideline for the Management of Adults with Congenital Heart Disease.Difficulty Level: Advanced

This episode also available on YouTube: https://youtu.be/IYTn5bjiHqY

Difficulty Level: Intermediate

You are listening to Hu Said: Guideline Lifeline
Please subscribe, rate, and support the channel! Ads help keep materials free for everyone.
More MedEd resources available at ⁠⁠⁠⁠www.rueyhu.com⁠⁠⁠⁠
Updates at Twitter/X: ⁠⁠⁠⁠@Ruey_Hu⁠